Prana Scientist to Participate in Webcast to Discuss Alzheimer’s Disease Therapeutics: Recent Setbacks and Emerging Technologies on Monday, October 1 July 17, 2013August 16, 2022
Alterity Therapeutics Enrolls First Patient in Australia in ATH434 Global Phase 2 Clinical Trial in Multiple System Atrophy May 10, 2023May 23, 2023
